Breast cancer patients.
Conditions
Interventions
Intervention 1: Intervention group: combination of spearmint _ Ginger capsules 500 mg containing 250 mg of ginger and 250 mg spearmint powder, every day two capsules will be given to chemotherapy pat
Sponsors
Sanandaj University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: History of at least one course of chemotherapy History of nausea and vomiting after previous chemotherapy sessions Definitive diagnosis of breast cancer by clinical trials and an oncologist
Exclusion criteria
Exclusion criteria: Having a history of allergy to ginger or mint and taking them over the past week Having other nausea-causing problems such as high blood pressure, liver failure, kidney problems and digestive problems Metastasis to other organs of other body systems
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of nausea, Severity of nausea, Incidence of vomiting. Timepoint: An hour before chemotherapy, during chemotherapy, first, second, third, fourth and fifth days of chemotherapy. Method of measurement: A questionnaire, an information recording form, and a standard analogue visual analogue tool. | — |
Secondary
| Measure | Time frame |
|---|---|
| . Timepoint: . Method of measurement: . | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactJamal Seidi
Sanandaj University of Medical Sciences
Outcome results
None listed